We are live on ! Find out more
CM

CM Management Portfolio holdings

AUM $120M
1-Year Est. Return 37.12%
This Fund
S&P 500
This Quarter Est. Return
+16.31%
1 Year Est. Return
+37.12%
3 Year Est. Return
+141.34%
5 Year Est. Return
+139.46%
10 Year Est. Return
–
AUM
$135M
AUM Growth
+$26.7M
Cap. Flow
+$13.4M
Cap. Flow %
9.95%
Top 10 Hldgs %
35.95%
Holding
101
New
21
Increased
28
Reduced
9
Closed
20

Top Buys

1
FOLD
Amicus Therapeutics
FOLD
+$5.57M
2
ALCO icon
Alico
ALCO
+$2.28M
3
ELTX icon
Elicio Therapeutics
ELTX
+$1.81M
4
EXEL icon
Exelixis
EXEL
+$1.81M
5
MRK icon
Merck
MRK
+$1.47M

Top Sells

1
ATER icon
Aterian
ATER
+$7.86M
2
AVNW icon
Aviat Networks
AVNW
+$3.95M
3
CLPT icon
ClearPoint Neuro
CLPT
+$3.34M
4
INTC icon
Intel
INTC
+$2.49M
5
GILD icon
Gilead Sciences
GILD
+$1.75M

Sector Composition

1 Healthcare 40.52%
2 Financials 13.92%
3 Technology 12.04%
4 Energy 10.02%
5 Materials 6.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STAY
101
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
– –
-30,000
Closed -$444K
1 2 3 4
5

Similar funds

AA
Ahara Advisors Jersey City, New Jersey $120M AUM
CC
Commons Capital Needham, Massachusetts $120M AUM 31.45% 1-Year Est. Return
DG
Dala Group Hoffman Estates, Illinois $120M AUM
ACM
AIHC Capital Management Central $120M AUM
WAG
Windsor Advisory Group Columbus, Ohio $120M AUM 4.29% 1-Year Est. Return
YMRC
Yorktown Management & Research Company Forest, Virginia $120M AUM 52.72% 1-Year Est. Return
IW
Integrated Wealthcare Durham, North Carolina $120M AUM
BCWM
Ball & Co Wealth Management Franklin, Tennessee $120M AUM 21.28% 1-Year Est. Return

CM Management's Q1 2021 Portfolio in Review

As of Q1 2021, CM Management held 101 positions worth $135M, up 25% from $108M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

CM Management deployed $13.4M of net new capital in Q1 2021, opening 21 new positions and adding to 28 existing holdings. Its largest new stake was Elicio Therapeutics: 9,375 shares worth $1.69M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 37% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Aterian, an estimated $7.86M trimmed.

  • CM Management's largest Q1 2021 buy was Elicio Therapeutics: 9,375 shares worth $1.69M.
  • CM Management added most to Amicus Therapeutics in Q1 2021, an estimated $5.57M increase.
  • CM Management's biggest Q1 2021 reduction was Aterian, cutting an estimated $7.86M.
  • CM Management fully exited Aviat Networks in Q1 2021, selling an estimated $3.95M.
  • CM Management's ten largest holdings make up 36% of its $135M portfolio in Q1 2021.
  • CM Management opened 21 new positions and closed 20 in Q1 2021.
  • CM Management's portfolio value rose 25% quarter-over-quarter to $135M.

Based on CM Management's 13F filing for Q1 2021, filed 12 May 2021.